ASCOT LABORATORIES LIMITED
Get an alert when ASCOT LABORATORIES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-02-28 (in 9mo)
Last filed for 2025-05-31
Confirmation statement due
2026-05-17
Overdue
Watchouts
Cash
£976K
+2,816.1% vs 2024
Net assets
£5M
+31.5% highest in 5 filed years
Employees
68
+3% highest in 5 filed years
Profit before tax
£1M
+89.4% vs 2024
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Confirmation statement overdue
Due 2026-05-17.
Net assets
6-year trend · vs Health Care median
Accounts
6-year trend · latest reflected 2025-05-31
| Metric | Trend | 2020-05-31 | 2021-05-31 | 2022-05-31 | 2023-05-31 | 2024-05-31 | 2025-05-31 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | £7,298,108 | £8,874,239 | |
| Operating profit | — | — | — | — | £931,115 | £1,569,491 | |
| Profit before tax | — | — | — | — | £668,795 | £1,266,723 | |
| Net profit | — | — | — | — | £668,795 | £1,194,769 | |
| Cash | £282,380 | £1,078,255 | £146,030 | — | £33,465 | £975,865 | |
| Total assets less current liabilities | £1,172,072 | £2,436,129 | £3,560,087 | — | £7,271,149 | £8,213,161 | |
| Net assets | £322,675 | £1,634,116 | £2,666,333 | — | £3,789,966 | £4,982,628 | |
| Equity | £322,675 | £1,634,116 | £2,666,333 | — | £3,789,966 | £4,982,628 | |
| Average employees | 35 | 42 | 55 | — | 66 | 68 | |
| Wages | — | — | — | — | £2,692,173 | £3,084,737 | |
| Directors' remuneration | — | — | — | — | £508,801 | £525,308 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2024 → FY2025 · period ending 2025-05-31 vs 2024-05-31
-
Turnover
+21.6%
£7,298,108 £8,874,239
-
Cash
+2,816.1%
£33,465 £975,865
-
Net assets
+31.5%
£3,789,966 £4,982,628
highest in 5 filed years
-
Employees
+3%
66 68
highest in 5 filed years
-
Operating profit
+68.6%
£931,115 £1,569,491
-
Profit before tax
+89.4%
£668,795 £1,266,723
-
Wages
+14.6%
£2,692,173 £3,084,737
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-05-31 | 2021-05-31 | 2022-05-31 | 2023-05-31 | 2024-05-31 | 2025-05-31 |
|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | 12.8% | 17.7% | |
| Net margin | — | — | — | — | 9.2% | 13.5% | |
| Return on capital employed | — | — | — | — | 12.8% | 19.1% | |
| Current ratio | — | — | — | — | 1.22x | 1.75x | |
| Interest cover | — | — | — | — | 3.53x | 4.90x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Sterling Young Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group and parent company's ability to continue as a going concern for a period of at least 12 months from when the financial statements are authorised for issue.”
Significant events
- “The increase in profitability reflects expanded product sales and cost efficiencies.”
- “The company intends to: Expand its pharmaceutical and diagnostic product pipeline”
- “The company intends to: Increase investment in research and development”
- “The company intends to: Strengthen international distribution channels”
- “The company intends to: Invest in laboratory technology and automation”
- “The company intends to: Enhance digital systems for quality and regulatory reporting”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 1 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| ALAM, Abdul Munaf | Director | 2013-02-26 | Mar 1968 | British |
| GHELANI, Deepak Anantrai | Director | 2011-01-21 | Jun 1961 | British |
| RADIA, Bhavesh Amratlal | Director | 2011-03-15 | Jun 1965 | British |
Show 1 resigned officer
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| SHALTIEL, Yaakov, Dr | Director | 2011-01-14 | 2011-01-14 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Bhavesh Amratlal Radia | Individual | Shares 25–50% | 2016-04-06 | Active |
| Mr Deepak Anantrai Ghelani | Individual | Shares 25–50% | 2016-04-06 | Active |
Filing timeline
Last 20 of 95 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-02-28 | AA | accounts | Accounts with accounts type group | |
| 2025-06-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-02-24 | AA | accounts | Accounts with accounts type total exemption full | |
| 2024-05-24 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-02-29 | AA | accounts | Accounts with accounts type total exemption full | |
| 2024-01-15 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-11-30 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-05-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-04-28 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2023-04-28 | CH01 | officers | Change person director company with change date | |
| 2023-04-28 | CH01 | officers | Change person director company with change date | |
| 2023-04-28 | AD01 | address | Change registered office address company with date old address new address | |
| 2023-02-28 | AA | accounts | Accounts with accounts type total exemption full | |
| 2022-05-13 | SH06 | capital | Capital cancellation shares | |
| 2022-05-13 | SH03 | capital | Capital return purchase own shares | |
| 2022-05-03 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-02-23 | AA | accounts | Accounts with accounts type total exemption full | |
| 2021-09-28 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2021-07-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-04-16 | AA | accounts | Accounts with accounts type total exemption full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.